Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium (Q36254199)

13 August 2017

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium (English)

1 reference

13 August 2017

1 reference

5

Giampaolo Merlini

1 reference

13 August 2017

Isabelle Lousada

1

1 reference

13 August 2017

Raymond L Comenzo

series ordinal

2

1 reference

13 August 2017

Heather Landau

series ordinal

3

1 reference

13 August 2017

Spencer Guthrie

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

23 October 2015

1 reference

13 August 2017

1 reference

13 August 2017

32

1 reference

13 August 2017

920-928

1 reference

13 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s12325-015-0250-0

13 August 2017

0 references

cites work

Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Immunoglobulin light chain amyloidosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Light-chain (AL) amyloidosis: diagnosis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Molecular mechanisms of amyloidosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

Systemic light chain amyloidosis: an update for treating physicians

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4635176

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12325-015-0250-0

Guidelines on the management of AL amyloidosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26498944

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12325-015-0250-0

1 reference

13 August 2017

1 reference

13 August 2017

1 reference